Pharmacy Compounding Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 13, 1997)
Pharmacy Compounding Act - Amends the Federal Food, Drug, and Cosmetic Act to make specified provisions of that Act inapplicable to a drug or device that is compounded by a licensed pharmacist, licensed physician, or other licensed practitioner authorized by State law to prescribe drugs or devices.
Declares null and void a proposed rule concerning exceptions to good manufacturing practices for makers of positron emission tomography drug products and a guideline on the manufacture of such products. Prohibits another proposed regulation or guideline on those matters.
What just happenedMar 21, 1997
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseMar 13, 1997
- Mar 21, 1997CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Mar 13, 1997IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Mar 13, 1997IntroReferralIntro-H
Introduced in House
- Mar 13, 1997IntroReferral1000
Introduced in House